» Articles » PMID: 22461533

Electrocardiogram Abnormalities and Cardiovascular Mortality in Elderly Patients with CKD

Overview
Specialty Nephrology
Date 2012 Mar 31
PMID 22461533
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Cardiovascular disease is the most common cause of death in CKD. This study evaluated whether electrocardiogram (ECG) abnormalities are predictors of cardiovascular death in CKD.

Design, Setting, Participants, & Measurements: The Cardiovascular Health Study limited database (1989-2005) was used to identify a cohort with CKD at baseline (estimated GFR < 60 mL/min per 1.73 m(2)). The patients were categorized as having major, minor, or no ECG abnormalities. Rates of adjudicated cardiovascular events and mortality were compared among the groups using proportional hazards regression models.

Results: A total of 1192 participants had CKD at baseline; mean age ± SD was 74.7±6.2 years. Of these patients, 452 (38.8%) had major, 346 (29.7%) had minor, and 367 (31.5%) had no ECG abnormalities. Participants with estimated GFR < 60 mL/min per 1.73 m(2) were more likely to have ECG abnormalities at baseline (adjusted prevalence odds ratio, 1.23 [95% confidence interval (CI), 1.06-1.43]) than those with GFR ≥ 60 mL/min per 1.73 m(2). During mean follow-up of 10.3±3.8 years, 814 (68.3%) participants died. Compared with participants without ECG abnormalities, participants with major abnormalities had the highest risk for cardiovascular events and death; adjusted hazard ratios were 2.15 (95% CI, 1.56-2.98) and 2.27 (95% CI, 1.56-3.30), respectively. For minor ECG abnormalities, hazard ratios were 1.24 (95% CI, 0.91-1.70) and 1.48 (95% CI, 1.00-2.18), respectively.

Conclusions: In patients with CKD, major ECG abnormalities are frequently present and predict a significantly higher risk for death and adverse cardiovascular outcomes.

Citing Articles

Sex-Specific Changes in Cardiac Function and Electrophysiology During Progression of Adenine-Induced Chronic Kidney Disease in Mice.

Dargam V, Sanchez A, Kolengaden A, Perez Y, Arias R, Valentin Cabrera A J Cardiovasc Dev Dis. 2024; 11(11).

PMID: 39590205 PMC: 11594452. DOI: 10.3390/jcdd11110362.


Advanced Interatrial Block across the Spectrum of Renal Function.

Marano M, Senigalliesi L, Cocola R, Fontana M, Parente E, Russo V Medicina (Kaunas). 2024; 60(6).

PMID: 38929618 PMC: 11205515. DOI: 10.3390/medicina60061001.


Comparison between beta-blockers and calcium channel blockers in patients with atrial fibrillation according to renal function.

Parada Barcia J, Raposeiras Roubin S, Fernandez D, Garcia A, Otero C, Gonzalez Bermudez I Clin Cardiol. 2024; 47(5):e24257.

PMID: 38664980 PMC: 11046037. DOI: 10.1002/clc.24257.


Association of abnormalities in electrocardiography and ultrasonic echocardiography with the occurrence of cardiovascular disease in patients with advanced chronic kidney disease.

Hirabayashi K, Fujii H, Kono K, Yamatani S, Shimizu M, Watanabe K Clin Exp Nephrol. 2023; 28(4):307-315.

PMID: 38141089 PMC: 10954921. DOI: 10.1007/s10157-023-02437-8.


Prevalence and Clinical Impact of Electrocardiographic Abnormalities in Patients with Chronic Kidney Disease.

Park S, Yum Y, Cha J, Joo H, Park J, Hong S J Clin Med. 2022; 11(18).

PMID: 36143060 PMC: 9506179. DOI: 10.3390/jcm11185414.